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Abstract
Human gammaherpesviruses are associated with the development of lymphoproliferative diseases and B cell lymphomas,
particularly in immunosuppressed hosts. Understanding the molecular mechanisms by which human gammaherpesviruses
cause disease is hampered by the lack of convenient small animal models to study them. However, infection of laboratory
strains of mice with the rodent virus murine gammaherpesvirus 68 (MHV68) has been useful in gaining insights into how
gammaherpesviruses contribute to the genesis and progression of lymphoproliferative lesions. In this report we make the
novel observation that MHV68 infection of murine day 15 fetal liver cells results in their immortalization and differentiation
into B plasmablasts that can be propagated indefinitely in vitro, and can establish metastasizing lymphomas in mice lacking
normal immune competence. The phenotype of the MHV68 immortalized B cell lines is similar to that observed in
lymphomas caused by KSHV and resembles the favored phenotype observed during MHV68 infection in vivo. All established
cell lines maintained the MHV68 genome, with limited viral gene expression and little or no detectable virus production -
although virus reactivation could be induced upon crosslinking surface Ig. Notably, transcription of the genes encoding the
MHV68 viral cyclin D homolog (v-cyclin) and the homolog of the KSHV latency-associated nuclear antigen (LANA), both of
which are conserved among characterized c2-herpesviruses, could consistently be detected in the established B cell lines.
Furthermore, we show that the v-cyclin and LANA homologs are required for MHV68 immortalization of murine B cells. In
contrast the M2 gene, which is unique to MHV68 and plays a role in latency and virus reactivation in vivo, was dispensable
for B cell immortalization. This new model of gammaherpesvirus-driven B cell immortalization and differentiation in a small
animal model establishes an experimental system for detailed investigation of the role of gammaherpesvirus gene products
and host responses in the genesis and progression of gammaherpesvirus-associated lymphomas, and presents a convenient
system to evaluate therapeutic modalities.
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Introduction
The human gammaherpesviruses EBV and KSHV are charac-
terized by their ability to establish latent infections and their close
association with a wide variety of malignancies [1]. EBV is the
etiologic agent of infectious mononucleosis, and is tightly associated
with development of endemic Burkitt’s lymphoma, 30–40% of
Hodgkin’slymphomaandnearlyhalf ofthe lymphomasthat arisein
immunosuppressed patients [2,3]. KSHV is present in all cases of
Kaposi’s sarcomas, and is also associated with the development of
the rare primary effusion lymphomas (PELs) that occur in some
AIDS patients [4,5]. In addition, KSHV is the etiologic agent of the
lymphoproliferative disorder Multicentric Castelman’s disease [6].
Both EBV- and KSHV-associated lymphoproliferative diseases and
B cell lymphomas mostly occur in immunodeficient individuals,
such as arising in HIV infected patients and following organ
transplantation. However, because of the narrow tropism of the
human gammaherpesviruses, no tractable small animal model is
available for dissecting the genesis of EBV- and KSHV-associated
lymphomas.
Gammaherpesviruses have been divided into 2 subfamilies – the
c1-herpesviruses (lymphocryptoviruses), of which EBV is a
member, and the c2-herpesviruses (rhadinoviruses), which include
KSHV and MHV68. All characterized lymphocryptoviruses share
the property of being able to growth transform primary B cells in
tissue culture. However, only the T lymphotropic rhadinoviruses
(herpesvirus saimiri and herpesvirus ateles) have been shown to
transform lymphocyte targets [7,8]. It has thus been generally
assumed that the B lymphotropic rhadinoviruses are non-
transforming, and this has significantly impeded studies into the
role of KSHV genes involved in the genesis of lymphomas and
lymphoproliferative disease. However, in the case of both KSHV
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due to their inability to efficiently infect primary B cells in tissue
culture [9] and/or the absence of appropriate culture conditions.
Here we explore this possibility by targeting virus infection of B
cell progenitor populations using fetal liver cells isolated from day
15 embryos cultured in the presence of IL-7 to drive B cell
differentiation.
Results
Generation of MHV68 immortalized B cell lines
Fetal liver is the major site of B lymphopoiesis during embryonic
development, prior to the initiation of B cell development in the
bone marrow [10]. The early progenitor cells from murine fetal
liver can differentiate into immature B cells upon co-culture with
IL-7 producing stromal cells in vitro [11,12] or into mature B cells
upon transfer into severe combined immunodeficient (SCID) mice
[13,14]. Using a recombinant MHV68 harboring a YFP
expression cassette, pilot experiments demonstrated that
MHV68 can infect fetal liver cultures derived from day 15 mouse
embryos (data not shown). This led to the development of a two-
stage culture strategy in which MHV68 infected fetal liver cells
were initially cultured on IL-7 expressing T220 fibroblasts [15] for
4 to 5 days to drive B lineage development, followed by transfer of
the infected fetal liver cells onto mouse embryo fibroblasts (MEFs)
(Fig. 1A). The T220 fibroblast and MEF monolayers are
permissive for MHV68 replication, and thus were destroyed after
several days of co-culture with the infected fetal liver cells. The
infected fetal liver cells were maintained as a bulk culture for 3-4
weeks to generate a sufficient population of infected YFP+ cells
that could then purified by flow cytometry (Fig. 1B). Cell lines
were generated from sorted YFP+ cells by either single cell sorting
or limiting dilution cell culture. Cell lines derived by this approach
displayed lymphoblastoid morphology with ovoid or slightly
elongated shape and the presence of villipodia projecting from
the cell surface (Fig. 1C), similar to the appearance of EBV
immortalized lymphoblastoid cell lines [16].
Surface staining demonstrated that all the cell lines established
bore cell surface markers characteristic of B lymphocytes (B220+/
CD19+/c-kit-/CD43-). Surprisingly, all cell lines were sIgD-/
sIgM-, suggesting that they either were arrested at an early stage of
development or had undergone isotype switching (Fig. 2 and data
not shown). Subsequent staining with a panel of isotype specific
antibodies revealed that these cell lines expressed surface
immunoglobulin, having undergone class switch recombination
to IgG2a (Fig. 2 and data not shown). Staining for light chain
usage revealed that all the cell lines were Igk+ and Igl- (Fig. 2).
Notably, even though these cell lines arose from fetal liver, all were
CD5- (Fig. 2). In addition, they were I-A
b intermediate or low and
CD138 (syndecan) intermediate or high (Fig. 2), suggesting that
these cell lines have differentiated toward a plasmablast pheno-
type. Consistent with this interpretation, ELISA analyses of the
culture supernatants demonstrated significant levels of secreted
IgG2a and kappa light chain (Fig. S1). Furthermore, cytoplamic
expression of IgG2a was detected in MHV68 immortalized cell
lines by immunofluorescent staining (Fig. S2). We also examined
the expression of germline transcripts directed by the I promoter of
each isotype (Fig. S3A), which revealed the presence of IgG2a
germline transcripts and low levels of IgG3 germ line transcripts
(Fig. S3A). After immunoglobulin class switch recombination
(CSR), post-switch transcripts containing the Im exon spliced to the
59 exon of the relevant rearranged isotype (directed by constitutive
active Im promoter) are generated [17,18]. Correspondingly, we
readily detected the expression of IgG2a post-switch transcripts
(Fig. S3A), and not any of the other immunoglobulin isotypes (data
not shown). The IgG2a post-switch transcripts were further
confirmed by cloning and sequencing the amplified PCR product
(Fig. S3B). Finally, consistent with the observation of class switch
recombination, RT-PCR analyses detected the expression of AID
in these cell lines (data not shown). Taken together, these data
support the conclusion that MHV68 infection of a fetal liver B cell
progenitor population(s) not only leads to their immortalization,
but also directs these cells to differentiate into IgG2a-expressing
plasmablasts.
Next, we determined the clonality of B cell lines transformed
by MHV68. Transformation of B lymphocytes by murine
retroviruses leads to outgrowth of transformed lines that are
oligo or pauciclonal in nature [19]. To determine the clonality of
the B cell clones we used primer sets capable of amplifying .98%
of rearranged Ig gene segments. We amplified and sequenced Ig
H chain gene segments from 2 of the established MHV68-
transformed B cell lines (Fig. S4). Surprisingly, we found that
these B cell lines exhibited high clonal diversity. Of the 16 H
chain gene segment sequences obtained, junction analyses
indicated that there were 10 unique junctions (Table S1). Further
analysis of JH usage, as well as V-region nucleotide sequence
comparison, revealed an additional 2 sequences which were
determined to be unique. Thus, 12 out of 16 (75%) heavy chain
sequences were unique. This data suggests that, unlike murine
leukemia virus, MHV68 transformation yields a polyclonal
population of immortalized B cells. This observed polyclonality
could be due to one of the two following reasons: (a) MHV68
targets and immortalizes a variety of mature B cells; or (b) the
Author Summary
Herpesviruses are ubiquitous viruses, members of which
infect all known mammalian species. A notable feature of
all herpesvirus infections is that these infections cannot be
cleared and persist for the lifetime of the host. In most
cases these infections are benign and often without
notable symptoms. However, for a subgroup of herpesvi-
ruses – the gammaherpesviruses – some infected individ-
uals develop lymphomas, as well as several other types of
cancer. There are two known gammaherpesviruses that
infected humans, Epstein-Barr virus (EBV) and Kaposi’s
sarcoma-associated herpesvirus (KSHV), both of which
have been the subject of intensive investigation. However,
a major shortcoming of research on these viruses is the
absence of an appropriate small animal model since these
viruses only infect humans. To circumvent this limitation,
infection of mice with a rodent gammaherpesvirus, murine
gammaherpesvirus 68 (MHV68), is being characterized.
Like EBV and KSHV, MHV68 infection of mice is also
associated with the development of lymphoma under
some experimental conditions. Here we show for the first
time that a hallmark of EBV infection of human B
lymphocytes – growth transformation of infected B cells
in tissue culture – can be recapitulated by MHV68 infection
of murine fetal liver-derived B cells. Furthermore, we
identify two MHV68 genes that are required for B cell
growth transformation. Finally, we show that MHV68
growth transformed B cell lines cause aggressive lympho-
mas in mice lacking an intact immune system, but not in
immune competent mice. The latter result opens the door
for studies on the role of viral genes in driving B cell
growth, as well as host immune responses that control
outgrowth of MHV68 infected B cells.
MHV68 Immortalization of Murine B Cells
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The latter seems likely since multiple junction sequences were
obtained within each of the 2 cloned cell lines analyzed, although
it is possible that only those wells that were seeded with more
than one MHV68 infected B cell grew out as cell lines. We also
analyzed VH segment usage from transformed B cells and all of
them were confined to the VH5 family (Table S2). This skewing
most likely reflects the predominant rearrangement of the D-
proximal VH5 family V gene segments in fetal liver, rather than
MHV68 transformation being restricted to select BCR-bearing B
cells.
Retention of viral genome and ability to trigger virus
reactivation in MHV68 immortalized B cell lines
Since mock infected day 15 fetal liver cell cultures did not survive
and expand following transfer of the cultures to mouse embryo
fibroblast feeder layers, we conclude that virus infection is required
for outgrowth of fetal liver-derived B cell lines using the assay
described above (Fig. 1A). To determine whether there is an
ongoing requirement for virus infection, we assessed the frequency
of cells harboring viral genome using a limiting-dilution PCR
analysis (Fig. 3A). These analyses demonstrated that the viral
genome is faithfully maintained in all the cell lines generated, even
afterserialpassageformorethan6monthsintissueculture(Fig.3A).
To assess viral gene expression in these B cell lines, semi-
quantitative RT-PCR analyses were performed for a panel of
candidate latency-associated and known replication-associated viral
genes (Fig. 3B). Tetradecanoyl-phorbol-13-acetate (TPA)-treated
A20-HE cells [20] (generated by MHV68 infection of the murine
A20 B cell line) served as a positive control for expression of
replication cycle-associated viral transcripts in the setting of virus
reactivation from B cells (Fig. 3B). Expression of the replication-
associated genes encoding the viral DNA polymerase (pol), major
capsid protein (MCP) and ORF25 were only detected at low
levels (Fig. 3B) in the MHV68 transformed B cell lines, consistent
with the majority of the infected cells being latently infected. This
was further underscored by detection of transcripts for the known
latency-associated genes M2, ORF 73 encoding the latency-
associated nuclear antigen (mLANA), and the viral bcl-2 homolog
(M11) (Fig. 3B). In addition, expression of viral genes that may
play a role in both latency and virus replication (v-cyclin, M8 and
K3) were also detected at significant levels in most of the
transformed cell lines.
A hallmark of herpesvirus latency is the ability to enter the viral
replication program (reactivation) given the appropriate stimulus
[21]. We assessed a panel of MHV68 transformed B cells lines for
induction of lytic antigen expression following treatment with
either TPA, crosslinking surface immunoglobulin, or addition of
lipopolysaccharide (LPS) to the culture medium. Somewhat
surprisingly, TPA did not trigger virus reactivation (Fig. 3C).
However, anti-Ig treatment was able to induce virus reactivation
in all cell lines tested - although output virus titers were low
(Fig. 3C and data not shown). This is reminiscent of the difficulty
in triggering EBV reactivation from LCLs generated using
umbilical cord lymphocytes compared to those generated from
adult peripheral B cells [22].
Figure 1. Generation of MHV68 immortalized fetal liver-derived B cell lines. (A) Two stages in vitro culture system for establishing MHV68
infected fetal liver-derived B cell lines. (B) Purification of MHV68-YFP infected fetal liver cells by flow cytometry. Shown are representative pre- and
post-sort analyses of YFP-expression. (C) Morphology of a representative MHV68-YFP infected culture at 2.5 weeks post-infection, showing extensive
clumping of cells and lymphoblastoid phenotype.
doi:10.1371/journal.ppat.1002220.g001
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immortalization of murine day 15 fetal liver-derived B
cells
To begin to assess the viral requirements for B cell
immortalization, we considered candidate latency-associated viral
genes for which we consistently detected transcripts in the MHV68
immortalized B cell lines (Fig. 3) and whose functions would
contribute to B cell immortalization. As such, we chose three viral
genes to analyze - two genes that are conserved among all known
rhadinoviruses (v-cyclin and LANA) and one gene that is unique to
Old World rodent rhadinoviruses (M2). The v-cyclin gene is an
obvious candidate to examine since we have previously shown that
it is capable of inducing lymphomas when expression was targeted
to T cells in transgenic mice [23]. Similarly, mLANA would be
expected to play a central role in B cell immortalization based on
the role of KSHV LANA in maintenance of the viral episome
during latency, as well as its role in regulating lytic gene
expression. The other candidate gene we examined is the M2
gene, a novel MHV68 gene product that we have shown can
enhance survival and proliferation of primary murine B cells [24].
Day 15 fetal liver cells were infected with either wild type virus, the
v-cyclin null virus (v-cyclin,Stop), mLANA null virus (mLANA.
Stop) or the M2 null virus (M2.Stop), and cultured as described
above. Notably, while wild type virus infected B cells formed
many colonies which were easily detected by light microscopy, the
v-cyclin.Stop virus infected B cells formed a small number of
disorganized colonies that were sparse in cell number and failed to
expand (Fig. 4 and Table 1). Fetal liver-derived B cells infected
with the mLANA.Stop virus also failed to generate any infected
foci, and YFP+ cells were rapidly lost in these cultures (Table 1). In
contrast, M2.Stop virus infected fetal liver-derived B cells formed
colonies from which YFP+ cells were isolated and immortalized
cell lines established (Table 1 and data not shown). It is perhaps
notable that the generation of immortalized cell lines from the
M2.Stop cultures appeared less efficient than that observed with
wild type MHV68 – however, this interpretation should be taken
with some caution because the assay used was not designed to be
quantitative.
Induction of lymphomas upon adoptive transfer of
MHV68 immortalized B cell lines into T cell-deficient mice
During EBV infection in immunocompetent individuals,
outgrowth of EBV growth transformed B cells is tightly controlled
by a vigorous CD8+ cytotoxic T lymphocyte (CTL) response
which targets viral antigens expressed in these B cells. Immune
suppression leading to diminished EBV-specific CTL responses
thus appears to be central in the progression of EBV-associated
lymphoproliferative disease and the genesis of lymphomas in AIDS
patients and organ transplant recipients. To determine whether
the MHV68 growth transformed B cell lines recapitulate features
of EBV in immuncompromised individuals, we assessed the ability
of the cloned cell lines to form tumors when injected either
subcutaneously or intraperitoneally into immunocompromised
mice (athymic nude mice or RAG2-/- mice) (Fig. 5). Importantly,
as expected, no tumors were observed when MHV68 infected fetal
liver-derived B cell lines were injected into either B cell-deficient
mice (mMT) or wild-type C57BL/6 mice (Fig. 5C) – demonstrating
that an intact host immune system is able to control outgrowth of
MHV68 transformed B cell lines. This is consistent with the
induction of T cell-mediated control of gammaherpesvirus
transformed B cells, as observed following EBV infection of
immunocompetent individuals. However, as expected, all of the
MHV68 infected B cell lines tested were tumorigenic in both
athymic nude (T cell-deficient) and RAG2-deficient (B and T cell-
deficient) mice, with the appearance of subcutaneous tumors or
tumors in lymph nodes appearing 14 to 28 days after injection of
cells (Fig. 5). All tumors showed characteristics of lymphomas
histopathologically, and all inoculated mice (following either
subcutaneous or intraperitoneal injection of tumor cells) showed
metastasis of these lymphomas to the spleen (Fig. 5B). The
presence of B cells in these lesions was verified by immunohisto-
chemical staining of tumor tissue sections. All tumor tissue sections
were homogeneously infiltrated with B220-expressing B cells (Fig.
S5). A low level of CD8+ T cells were apparent in the spleens of
mock infected nude mice, but not in spleens recovered from mice
inoculated with the MHV68-infected fetal liver-derived B cell lines
(Fig. S5). Explanted tumors could readily be cultured ex vivo, were
viral genome positive, and exhibited a similar pattern of viral gene
and cell surface marker to the parental cloned cell lines (Fig. S6
and data not shown). However, it is notable that all the explanted
tumor cell lines had upregulated expression of CD5 and expressed
higher levels of MHC II than the parent cell lines (Fig. S6B). The
upregulation in CD5 expression resonates with the ability of fetal
liver-derived B cell progenitors to effectively reconstitute CD5
+ B
cells in vivo [25,26].
Discussion
The ability to study the pathogenesis of EBV and KSHV in the
infected host has been significantly hampered by the lack of robust
small animal models. Although significant progress has been made
in the generation of humanized mice, most notably using NOD/
SCID/IF2Rc
null mice as recipients of human hematopoietic stem
cells, the T cell responses that are generated are clearly not normal
and, at least in the case of EBV infection, are ultimately
insufficient to control virus infection [27,28,29]. Similarly, while
a number of important insights have been gained from the
generation of various transgenic mice (e.g., those harboring the
KSHV LANA gene and associated regulatory elements)
[30,31,32,33,34], this approach cannot assess the contribution
that host immune control and selection play in the genesis of
gammaherpesvirus-associated lymphoproliferative diseases. Non-
human primate models offer the possibility to fully explore the
pathogenesis of gammaherpesviruses that are very closely related
to the human pathogens (rhesus lymphocryptovirus and rhesus
rhadinovirus), but to date only limited studies have been carried
out using these models - presumably due to the substantial expense
associated with breeding gammaherpesvirus-free colonies of
Rhesus macaques. Thus, the MHV68-mouse model stands alone
as the only tractable small animal model that has been extensively
studied.
A detailed analysis of viral gene expression in established
MHV68 immortalized B cell lines will be required before all the
viral genes required for immortalization can be determined.
However, our initial characterization of viral transcripts detected
in these B cell lines identified several viral genes whose products
are candidates for being involved in driving B cell survival and/or
Figure 2. Surface phenotyping MHV68 infected cell lines derived from infection of day 15 fetal liver cells. Cell surface expression was
analyzed for individual cell lines derived from single cell cloning by flow cytometry. Day 15 fetal liver cells (FLC d15) and splenocytes harvested from
naive C57BL/6 mice (BL6 splenocytes) were used as staining controls.
doi:10.1371/journal.ppat.1002220.g002
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shown here that both the v-cyclin and mLANA are required for
immortalization of fetal liver-derived B cells. The latency genes K-
cyclin and LANA, homologs of MHV68 v-cyclin and mLANA,
are expressed in all KSHV-associated maglinancies, Kaposi’s
sarcomas (KS), primary effusion lymphomas (PEL) and multicen-
tric Castleman’s diseases (MCD) [35,36,37,38]. Furthermore K-
cyclin, which modulates the cell-cycle by phosphorylation of p27
in PEL cells, has been implicated in the development of KS tumors
and the induction of lymphomas by cooperating with p53 loss
[39,40,41]. The MHV68 v-cyclin has also been shown to be an
oncogene [23]; mice harboring a v-cyclin transgene under the
control of the lck proximal promoter (active during early T cell
development) develop high grade lymphoblastic lymphomas. Here
we detected the expression of v-cyclin mRNA prior to the
induction of reactivation and expression of v-cyclin protein after
anti-Ig cross-linking to induce reactivation in MHV68 transformed
FL cells. Furthermore, v-cyclin null virus induced abortive
transformation of fetal liver-derived B cells, indicating that v-
cyclin is essential for MHV68 growth transformation of murine B
cells. In this light, the v-cyclin gene has been shown to promote
MHV68-infected primary endothelial cell survival [42]. The
mechanism(s) by which v-cyclin contributes to B cell immortali-
zation is currently under investigation, but likely involves a cdk-
dependent activity.
LANA, a conserved rhadinovirus gene, has been shown to be
expressed in every KSHV-associated malignancy examined. Thus,
LANA has a strong likelihood of being critically involved in the
formation of rhadinovirus tumors, but to date, this fact has not
been shown in the context of virus infection. Our data
demonstrate a requirement for mLANA in MHV68 growth
transformation of murine B cells, suggesting the conserved
function to KSHV LANA homolog. KSHV LANA exhibits
transforming properties in primary rat fibroblasts [43]. Similar to
v-cyclin-expressing transgenic mice, the KSHV LANA homolog
has been shown to be a potent inducer of B cell tumors when
expressed in transgenic mice [35]. Further, LANA was shown to
give a significant survival advantage to B cells responding to
antigen [44]. The mechanisms responsible have not yet been
clearly identified, but LANA has been observed interacting with
many proteins involved in cell growth pathways, inhibiting p53-
mediated apoptosis [45] and regulating the cell cycle [43,46,47].
During primary infection of fibroblasts, mLANA has been shown
to be required for efficient replication of the virus, and in the
absence of mLANA, the virus shows dysregulated expression of
viral genes and an early hyperlytic phenotype, resulting in a lower
output of virus overall [48]. These data are consistent with the
observation in KSHV that LANA may interact directly with and
downregulate transcription from the immediate-early ORF50
promoter [49]. These data, taken together argue strongly for the
requirement of mLANA in the efficient development of MHV68-
derived tumors. mLANA likely sets the stage for transformation,
by interacting with and altering pro-growth and anti-apoptotic
pathways, stabilizing the cell and by turning off lytic genes,
preventing the infected FL cells from succumbing to lytic infection.
This is not to say LANA is a strict requirement for rhadinovirus
transformation--MHV68 can establish latency in the absence of
mLANA [50] and EBV can establish LCLs in the absence of the
major latency-associated protein EBNA-1, though the process is
less efficient by several thousandfold [51]. Further investigation of
the role of mLANA in MHV68 transformation is planned.
Gammaherpesviruses encode homologs of cellular antiapoptotic
BCL-2 proteins (vBCL-2), inhibiting apoptosis in response to
diverse stimuli. EBV-encoded BHRF1 and BALF1, two vBCL-2
homologs, KSHV-encoded vBCL2, as well as MHV68-encoded
vBCL-2 exhibit antiapoptotic functions which protect the infected
cells from apoptosis induced by the host anti-viral immune
responses [52]. MHV68 vBCL-2 has been shown to be important
during MHV68 chronic infection and disease, but not acute
infection [53]. Recently, it has also been shown to antagonize the
host autophagy during MHV68 persistent infection [54]. The
oncogenic potential of vBCL-2 is an obvious candidate for analysis
in B cell immortalization.
There are also strong parallels between the observed phenotype
of the MHV68 transformed B cell lines and the previously
characterized impact of M2 protein expression on B cell growth
and differentiation [24,55]. We have previously shown that
expression of M2 in primary murine B cells enhances survival
and proliferation, both of which are dependent on M2 induction
of cellular IL-10 expression [24]. M2 expression also drives B cell
differentiation – including CSR, downregulation of MHC II and
B220 surface expression and upregulation in surface syndecan
expression and secreted IgG, consistent with differentiation toward
a plasmablast phenotype [24]. Furthermore, the observation that
the 12 cell lines characterized had isotype switched to IgG2a
recapitulates a bias observed during MHV68 infection in vivo,
where nearly half of the infected B cells detected in the spleen at
the peak of latency are IgG2a+. Importantly, this phenotype in
vivo is dependent on a functional M2 gene product. Finally, we
have previously shown that the presence of MHV68 in plasma
cells during virus infection in mice is dependent on the presence in
the virus of a functional M2 gene [55]. Studies are underway to
define how viral genes regulate MHV68 immortalization of fetal
liver-derived B cells.
In summary, we have demonstrated that infection of fetal liver
progenitor B cells overcomes a barrier previously encountered in
studies attempting to generate MHV68 transformed B cell lines
using mature B lymphocytes [9]. This may have implications to
studies of KSHV, which to date have failed to show any B cell
transforming activity. The ability to transform murine B cells with
MHV68 opens the door to developing the mouse model of
gammaherpesvirus infection to dissect the mechanisms through
which gammaherpesviruses manipulate B cell biology and
contribute to B cell lymphomagenesis. Importantly, the ability of
these cell lines to generate tumors in athymic nude mice and
Rag2-/- mice, but not in either C57Bl/6 or B cell-deficient mice,
underscores the critical role of T cells in controlling the outgrowth
of MHV68 latently infected B cells. The adoptive transfer of
MHV68 immortalized B cell lines has the added advantage that
there appears to be little or no reactivation disease apparent in
Figure 3. Analyses of viral genome frequency, viral gene expression and induction of virus reactivation from MHV68 immortalized
B cell lines. (A) The MHV68 genome is stably maintained in the established fetal-liver derived B cell lines. Shown was limiting dilution PCR detection
of the MHV68 genome. The intersection of the horizontal and vertical dashed lines depicts the predicted point, based on a Poisson distribution,
where every cell harbors viral genome. (B) Semi-quantitative RT-PCR of a panel of viral genes known to be associated with either virus replication
and/or latency. cDNA synthesized from total RNA isolated from individual cell lines was serially diluted 1:1, 1:5, or 1:25 prior to PCR amplification. (C)
Immunoblot analyses of viral lytic gene expression after treating cells with candidate reactivation stimuli. The cells were stimulated with the indicated
reagents for 72 hr, followed by immunoblot detection with either a rabbit anti-MHV68 antiserum, a chicken anti-ORF59 antibody, a rabbit anti-vCyclin
antibody or a mouse anti-actin antibody.
doi:10.1371/journal.ppat.1002220.g003
MHV68 Immortalization of Murine B Cells
PLoS Pathogens | www.plospathogens.org 7 September 2011 | Volume 7 | Issue 9 | e1002220these animals – an issue that complicates studies of MHV68
infected immunocompromised mice where a number of cellular
reservoirs (e.g., infected macrophages) ultimately contribute
significantly in the setting of immunocompromise to disease
associated with MHV68 replication [56]. The latter likely
obscures, at least in some settings, the detection and/or
development of MHV68-associated lymphomas since this may
lag behind the development of end-stage reactivation disease.
Finally, we anticipate that this new model will also facilitate studies
to identify cellular factors contributing to the generation of
gammaherpesvirus-associated B cell lymphomas.
Figure 4. The MHV68 cyclin D homolog is required for immortalization of fetal liver-derived B cells. Fetal liver (FL) cells, isolated from
embryos at day 15 of gestation, were infected with wild-type (WT) MHV68-YFP or v-Cyclin.Stop-YFP viruses at an MOI of 10 by spinoculation. (A)
Colonies were readily apparent in WT infected FL cell cultures by 2.5 weeks post-infection, but not in v-Cyclin.Stop-infected FL cell cultures. (B andC )
The colonies derived from WT-infected FL cells grew rapidly and contained numerous YFP bright cells. In contrast, there was little evidence of cellular
proliferation or colony formation in the v-Cyclin.Stop infected FL cell cultures. The images were taken at magnification 200X (A) or 100X (B and C), and
both brightfield (top panels) and YFP-fluorescence images (bottom panels) are shown.
doi:10.1371/journal.ppat.1002220.g004
Table 1. Immortalization of FL-derived B cells.
Virus Colony formation
WT +++
M2.Stop ++
v-cyclin.Stop +/-
mLANA.Stop -
doi:10.1371/journal.ppat.1002220.t001
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PLoS Pathogens | www.plospathogens.org 8 September 2011 | Volume 7 | Issue 9 | e1002220Figure 5. Induction of lymphomas by MHV68 immortalized FL cell lines in athymic nude and Rag 2-deficient mice. (A) Subcutaneous
tumors at the site of injection on the rear flank of Nu/J mice (upper panel). Also shown in a representative H&E stained tumor section (lower panel).
(B) Representative H&E stained tumor sections of either mock treated or Nu/J mice inoculated intraperitoneally with the SL-1 MHV68 transformed B
cell line. Lymphomas were apparent in both the spleen and lymph node in Nu/J mice injected with MHV68 immortalized FL cell lines. (C) Summary of
lymphoma induction using the indiciated MHV68 immortalized B cell lines inoculated into athymic nude, Rag 2-deficient, C57Bl/6 or MuMT (B cell-
deficient) mice.
doi:10.1371/journal.ppat.1002220.g005
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Ethics statement
This study was carried out in strict accordance with the
recommendations in the Guide for the Care and Use of
Laboratory Animals of the National Institutes of Health. The
protocol was approved by the Emory University Institutional
Animal Care and Use Committee, and in accordance with
established guidelines and policies at Emory University School of
Medicine (Protocol Number: 046-2010).
Viruses, cell culture, mice
Murine gammaherpesvirus 68-YFP (MHV68-YFP), M2.Stop-
YFP, mLANA.Stop-YFP, and v-Cyclin.Stop-YFP viruses were
prepared as previously described [55]. C57Bl/6 mice, Nu/J nude
and RAG-2-/- mice were sterile housed, treated and bred with the
approval of the Emory University Institutional Animal Care and
Use Committee, and in accordance with established guidelines
and policies at Emory University School of Medicine (Atlanta,
GA). IL-7-expressing T220 fibroblasts [15] and mouse embryo
fibroblasts (MEF) were cultured in DMEM medium with 10%
FCS, 100 U/ml penicillin and 100 mg/ml streptomycin.
Generation of MHV68 immortalized fetal liver cell lines
Fetal liver (FL) cells were obtained at day 15 of gestation. The
dispersed cells were washed with PBS and resuspended in RPMI
1640 medium with 5% FBS, 100 U/ml penicillin and100 mg/ml
streptomycin. Fetal liver cells were infected at an MOI=10 with
either wild type or specific MHV68 mutants. All viruses used
harbored a yellow fluorescent protein transgene expression
cassette introduced between orf 29a and orf 27 in the viral
genome, as previously described [57]. Fetal liver cells were mixed
with virus in the presence of polybrene (5 mg/ml), and plated into
6-well plates seeded with IL-7 expressing fibroblasts (either the
T220 or LTK cell lines). Spinoculation was carried out by
centrifugation at 1800rpm for 1 hr at room temperature, followed
by incubation at 37uC for 5 days. At day 5 post-infection, live cells
were transferred onto MEF monolayers for 3 to 4 days, followed
by culturing for 2 to 4 weeks to obtain sufficient cell numbers to
allow MHV68 infected YFP-positive cells to be recovered by flow
cytometry. During this expansion the cultures were fed weekly.
The sorted YFP positive cells were subcloned in 96-well plates,
either by limiting dilution cloning or single cell sorting by flow
cytometry. Cell lines were recovered and further cultured in RPMI
1640 medium with 5% FBS, 100 U/ml penicillin and 100 mg/ml
streptomycin.
Flow cytometry and fluorescence activated cell sorting
(FACS)
Flow cytometric analyses were done as previously described
[55]. Briefly, single-cell suspensions were incubated with PE-,
PerCP-, APC, APC-Cy7, and/or PacBlue-conjugated mAb on ice
for 15 min, and then washed with 0.5% FBS/PBS. The stained
cells were subjected to analyses on a LSRII flow cytometer (BD
Biosciences). The antibodies used for staining were purchased
from BD Biosciences except where noted, including: APC-anti-
CD117 (C-kit) , PE-anti-CD43, APC-anti-CD19, APC-Cy7-anti-
B220, PerCP-anti-IgM, PE-anti-IgD, PerCP-anti-CD5, PE-anti-
IA
b, PE-anit-CD138, PE-anti-IgG2a (Southern Biotech), PE-anti-
IgG2b (Southern Biotech), PE-anti-Igk (Southern Biotech), anti-
Igl (Southern Biotech). For YFP-positive cell sorting, the single
cell suspensions were resuspended with 0.5%FBS/PBS and
directly subjected to separation on a FACSAria
TM II flow
cytometer (BD Biosciences).
Analysis of immunoglobulin gene rearrangements
RNA was prepared from two representative MHV68 trans-
formed B cell lines, and RT-PCR performed to amplify VH gene
segments. Primers for immunoglobulin heavy chain variable
regions were made by creating consensus primers from VH
sequences obtained from the international ImMunoGeneTics
Information system (www.imgt.org). Consensus primers were
designed for each VH family and specific primers were made for
all four Jh segments. PCR amplification for heavy chains were run
using pooled VH and JH primers and high-fidelity Taq
polymerase. PCR products were cloned and sequenced. Heavy
chain sequences were input into the IMGT program V-QUEST
for analysis.
Immunoglobulin Isotyping
1-2610
6 cells of representative MHV68 immortalized FL-
derived cell lines were plated in 6-well plates, supernatants were
collected after culturing cells for 5 days and subjected to antibody
isotyping using an ELISA mouse mAb isotyping kit (Thermo
scientific), based on manufacturer’s instructions. Each cell line was
analyzed in triplicate.
Immunofluorescence staining, immunohistopathology
and immunohistochemistry
For histopathological analyses, tissues were fixed in formalin,
dehydrated, and embedded in paraffin. The embedded tissues
were cut at about 5 mm of thickness prior to staining with
hematoxylin and eosin for histopathological analyses. For
immunohistochemical analyses, the sections were deparaffinized,
rehydrated and incubated with citrate buffer (pH 6) for antigen
retrieval before the sections were subjected to immunofluorescence
staining. The stained slides were dehydrated in 95%, 100%
ethanol and xylene. Anti-fade mounting medium (Invitrogen) with
DAPI counterstaining (Invitrogen, USA) were used prior to
examining tissue sections on a LSM510 META confocal
microscope (Zeiss). The reagents used for the tissue section
staining included: biotin anti-mouse CD8a (BD Biosciences),
purified rat anti-mouse CD45R (B220) (BD Biosciences), Alexa
fluor 647-conjugated streptavidin and Alexa fluor 555-conjugated
secondary antibodies (Invitrogen).
Limiting dilution PCR analyses
The frequency of MHV68 genome-positive cells was deter-
mined using a previously described nested PCR assay (LD-PCR)
[58]. Briefly, cells were counted, resuspended in an isotonic
solution, and diluted into a background of 10
4 uninfected NIH
3T12 cells. Following cell lysis with proteinase K, two rounds of
nested PCR were performed on each sample to detect the
presence of the MHV68 ORF50. To ensure sufficient sensitivity of
the nested PCR reaction, 10, 1, or 0.1 copies of a gene 50
containing plasmid (pBamH I N) were diluted into a background of
10
4 uninfected cells and analyzed in parallel with the experimental
sample.
RT-PCR and semi-quantitative RT-PCR
Total RNA was extracted from the cells using TRIzol reagent
(Invitrogen) according to manufacturer’s instructions. 2 mg RNA
were used for first-strand cDNA synthesis (Invitrogen) prior to
PCR analysis. For semi-quantitative RT-PCR analyses of viral
gene expression, viral transcripts were amplified from serial
dilutions of cDNA (1:1, 1:5 and 1:25) in 35 cycles of PCR using
primers previously described [20]. cDNA from the reaction
without reverse transcriptase was used as a negative control for
MHV68 Immortalization of Murine B Cells
PLoS Pathogens | www.plospathogens.org 10 September 2011 | Volume 7 | Issue 9 | e1002220the PCR reaction. RNA derived from HE2 cells, treated with TPA
to trigger virus reactivation, served as a positive control for viral
gene expression. For PCR of viral gene expression from explant-
derived tumor cells, viral gene transcripts were amplified from
cDNA directly without dilution.
Germline immunoglobulin gene and postswitch transcripts were
amplified by PCR as previously described [18]. For PCR of B cell-
associated genes, the following primers were used to obtain the
indicated products: AID-F: 59-ACATCTCAGACTGGGAC-
CTG-39, AID-R: 59-TCAAAATCCCAACATACGAAATG-39;
PAX5-F: 59-AACTTGCCCATCAAGGTGTC-39, PAX5-R: 59-
CTGATCTCCCAGGCAAACAT-39; PU.1-F: 59 CCCTCCA-
TCGGATGACTTGGTTAC-39, PU.1-R: 59-GCTTCTCCAT-
CAGACACCTCCAGG-39; CD79a-F: 59- GTGAAAACAATG-
GCAGGAA-39, CD79a-R: 59- AGGTTCAGGCCCTCATA-
GAG-39; CD79b-F: 59-TCTCAGAAGAGGGACGCATT-39,
CD79b-R: 59- AATGTTCAAGCCCTCATAGG-39; J chain-F:
59-ATGAAGACCCACCTGCTT CTC-39, J chain-R: 59-GTC-
AGGGTAGCAAGAATCG GG-39; GAPDH-F: 59-CCATCAC-
CATCTT CCAGGAG-39, GAPDH-R: 59-CCTGCTTCACCA-
CC TTCTTG-39.
Reactivation stimulation and immunoblots
MHV68 immortalized FL cell lines were treated with 20 ng/ml
12-O-tetradecanoyl-phorbol-13-acetate (TPA), F(ab9)2 anti-mouse
IgG (5 mg/ml), LPS (10 mg/ml), trichostatin A (5 mM), sodium
butyrate (2 mM), or 5-azacytidine (5 mM) for 48 hr prior to the
harvest. Immunoblot analyses were performed as previously
described [20] to detect lytic viral antigen expression.
Lymphoma induction in immunodeficient mice
The tumorigenic ability of MHV68 immortalized cell lines was
tested in 6 to 8 week-old female Nu/J nude mice which were
purchased from The Jackson Laboratory, or RAG2-/- mice which
were bred at Emory University. Cells were suspended in PBS and
injected subcutaneously or intraperitoneally at a concentration of
2.5-5610
6 cells in a volume of 0.2 ml. Control mice were injected
with PBS. The animals were euthanized by carbon dioxide
inhalation when visible tumors reached a diameter of 1-2 cm. All
animals were autopsied and examined for metastases. Tumors
were excised under sterile conditions and divided into two
fragments, one of which was fixed in 10% neutral buffered
formalin (Sigma) and processed for histopathology and immuno-
histochemistry and the other fragment was explanted into cell
culture in RPMI 1640 medium with 10% FCS, 100 U/ml
penicillin and100 mg/ml streptomycin.
Supporting Information
Figure S1 Presence of secreted IgG2a in the superna-
tants of MHV68 immortalized fetal liver-derived B cell
lines. Immunoglobulin isotyping of supernatants recovered from
MHV68 immortalized B cell lines is shown. Supernatants were
collected from different MHV68 immortalized cell lines at day 5
after passage as described in Materials and Methods.
(TIF)
Figure S2 Presence of cytoplasmic IgG2a in MHV68
immortalized fetal liver-derived B cell lines. MHV68
immortalized fetal liver cells were fixed and stained with anti-
IgG1, -IgG2a, or -IgG3. DAPI was used to counterstain nuclei.
Splenocytes from C57BL/6 mice treated as indicated were used as
positive controls.
(TIF)
Figure S3 Detection of both germline and post-switch
immunoglobulin transcripts. (A) Detection of germline and
post-switch transcripts arising from theimmunoglobulin heavy chain
locus.Aschematicillustrationofgermlineandpost-switchtranscripts
is shown. RT-PCR of germline transcripts containing I promoter
and CH exonofthe sameisotype areshown inthe upperpanel,while
RT-PCR of IgG2a post-switch transcripts containing Im promoter
sequences spliced to the C2a exon is shown in the lower panel.
Splenocytes from C57BL/6 mice treated as indicated served positive
controls. (B) Nucleotide sequence of IgG2a post-switch transcript
cloned from representative MHV68 transformed SL-1 cell line.
(TIF)
Figure S4 Amino acid sequence alignment of Ig heavy
chain variable region sequences amplified from two
MHV68 transformed B cell lines. Sequences from the SL-1
(denoted with the prefix H1) and SL-6 (denoted with the prefix
H6) cell lines are shown. Sequences were aligned to the most
closely related germ line V segment sequence. These analyses
reveal the presence of multiple distinct variable region sequences
in each cell line, demonstrating that these cell lines are not clonal.
(TIF)
Figure S5 Detection of B cells in spleen and lymph node
sections. Sections from spleen, lymph node and subcutaneous
(SC) tumors homogeneously express the B cell surfacemarker B220.
Staining of tumors obtained from athymic nude mice are shown.
Note, there is a low level of CD8+ T cells inmock treated nude mice
in the spleen and lymph nodes, but these are not observed in the
tumor sections. DAPI was used to counterstain nuclei.
(TIF)
Figure S6 Explanted tumor cells exhibited similar viral
gene and cell surface marker expression as parental cell
lines. (A) RT-PCR of viral gene expression for explant cells from
subcutaneous tumors (SCT) and lymph node tumors (LNT). Two
cell lines along with the cells explanted from two individual mice
tumors derived from SC or IP injection are shown. (B) Explanted
tumor cell lines express surface B220, IgG2a, MHC class II, CD5
and CD138.
(TIF)
Table S1 Analysis of rearranged heavy chain VDJ
junctions. VDJ junctions were PCR amplified from cDNA
prepared from 2 representative MHV68 immortalized B cell lines,
as described in Materials and Methods.
(TIF)
Table S2 Identification of germline segments rear-
ranged in immunoglobulin heavy chain sequences. From
the analyses of rearranged heavy chain VDJ junctions, germline V
and J segments were identified. In addition, in some cases the
rearranged D segment could also be identified. In almost all cases
the V segment sequences closely matched the germline V
sequence.
(TIF)
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